State-of-the-Art Drug Discovery and Development in Spain

Dear Colleagues,

This Special Issue focuses on State-of-the-Art Drug Discovery and Development in Spain, in its broadest sense. Drug discovery and development is a rapidly changing and very dynamic arena, and Spain is one of the European hubs driving new knowledge both in academia and industry. In spite of the continuous advances, constant health challenges appear, as we have witnessed these last years with the global COVID-19 pandemia or with different pathologies that represent important threats to our daily well-being, in the current moment or in the near future, such as cancer, viral and bacterial infections, cardiovascular and neurodegenerative diseases, and ageing.

Therefore, we invite all authors actively contributing to the Spanish drug discovery and development arena to participate in this Special Issue. Original research articles and reviews dealing with new strategies with the potential to provide novel treatments in the short term will be welcomed, as will manuscripts dealing with the hottest topics in drug discovery and cutting-edge methodological advances, including emerging industry trends and strategies in relationship with recent drug approvals.

Prof. Dr. Silvia Ortega-Gutierrez
Prof. Dr. María L. López-Rodríguez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.